US-based pharmaceutical company Catalent Pharma Solutions plans to raise $450m through the private placement of senior unsecured notes, due 2026.

The company plans to use the funds for the acquisition of Cook Pharmica.

Hong Kong-based pharmaceutical and health products manufacturer China Grand Pharmaceutical and Healthcare Holdings (formerly Maxx Bioscience Holdings) has announced the private placement of 47 million shares priced at HK$2.24 ($0.29) a share to raise HK$106.96m ($13.7m).

US-based biotechnology company Recursion Pharmaceuticals and Japanese firm Takeda Pharmaceutical have signed a research agreement to use the former’s AI-augmented phenotypic discovery platform to develop pre-clinical candidates for the latter.

Takeda will initially make an upfront payment of $90m followed by royalty payments from the sale of new drugs.

“Ferring Pharmaceuticals has signed an agreement with Antares Pharma to acquire the worldwide rights to the latter’s ZomaJet needle-free auto injector device for $14.5m.”

Ferring Pharmaceuticals has signed an agreement with Antares Pharma to acquire the worldwide rights to the latter’s ZomaJet needle-free auto injector device for $14.5m.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The acquisition will strengthen Ferring Pharma’s growth hormone product portfolio.

Both companies involved in the deal are based in the US.

US-based biopharmaceutical company AbbVie has signed a worldwide research licensing agreement with Canadian immuno-oncology company Turnstone Biologics for three of the latter’s oncolytic viral immunotherapies.

The three therapies are under development and based on the Maraba virus.